Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Editorial: Escalation to weekly dosing in adalimumab-treated patients with active ulcerative colitis

Ward MG, Sparrow MP

(2014), Aliment Pharmacol Ther, 40(6), 730-1

Optimizing conventional medical therapies in inflammatory bowel disease in 2014

Asthana AK, Sparrow MP, Peyrin-Biroulet L

(2014), Curr Drug Targets, 15(11), 1002-10

Pharmacokinetics in IBD: ready for prime time?

Roblin X, Rinaudo M, Sparrow MP, Moreau A, Phelip JM, Genin C, Lamarque D, Paul S

(2014), Curr Drug Targets, 15(11), 1049-55

The role of thiopurine metabolite monitoring in inflammatory bowel disease

Beswick L, Friedman AB, Sparrow MP

(2014), Expert Rev Gastroenterol Hepatol, 8(4), 383-92

Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease

Fan F, Galvin A, Fang L, White DA, Moore XL, Sparrow M, Cicuttini F, Dart AM

(2014), J Inflamm, 11(1), 29

A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients

Lontos S, Shelton E, Angus PW, Vaughan R, Roberts SK, Gordon A, Gow PJ

(2014), J Dig Dis, 15(5), 260-7

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Var

(2014), J Hepatol, 61(6), 1238-46

Noninvasive tests for assessing liver fibrosis

Kemp W, Robert S

(2014), Med Today, 15(4), 65-7

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balik I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen P

(2014), J Viral Hepat, 21 Suppl 1, 34-59

Strategies to manage hepatitis C virus (HCV) disease burden

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balik I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christens

(2014), J Viral Hepat, 21 Suppl 1, 60-89

Historical epidemiology of hepatitis C virus (HCV) in selected countries

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balik I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, C

(2014), J Viral Hepat, 21 Suppl 1, 5-33

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

Sievert W, Razavi H, Estes C, Thompson AJ, Zekry A, Roberts SK, Dore GJ

(2014), J Gastroenterol Hepatol, 29 Suppl 1, 1-9

Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis

Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK

(2014), J Hepatol, 61(6), 1247-52

ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response

Holmes JA, Roberts SK, Ali RJ, Dore GJ, Sievert W, McCaughan GW, Crawford DH, Cheng WS, Weltman MD, Bonanzinga S, Visvanathan K, Sundararajan V, Desmond PV, Bowden DS, Matthews GV, Thompson AJ; CHARIOT Study Group

(2014), Hepatology, 59(6), 2152-60

Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies

Roberts SK, Mitchell J, Leung R, Booth D, Bollipo S, Ostapowicz G, Sloss A, McCaughan GW, Dore GJ, Thompson A, Crawford DH, Sievert W, Weltman M, Cheng W, George J; Australian Liver Association Clinical Research Network

(2014), J Gastroenterol Hepatol, 29(1), 179-84

Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis

Lee AL, Button BM, Denehy L, Roberts SJ, Bamford TL, Ellis SJ, Mu FT, Heine RG, Stirling RG, Wilson JW

(2014), Respirology, 19(2), 211-7

Increased risk of colorectal neoplasia in adult patients with cystic fibrosis: a matched case-control study

Gory I, Brown G, Wilson J, Kemp W, Paul E, Roberts SK

(2014), Scand J Gastroenterol, 49(10), 1230-6

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients

Kitson MT, Kemp W, Roberts SK, Murnane L

(2014), J Hepatol, 60(3), 676-7

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy

Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP

(2014), Clin Gastroenterol Hepatol, 12(1), 64-71

Risk factors for intraprocedural and clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions

Burgess NG, Metz AJ, Williams SJ, Singh R, Tam W, Hourigan LF, Zanati SA, Brown GJ, Sonson R, Bourke MJ

(2014), Clin Gastroenterol Hepatol, 12(4), 651-661

17 18 19 20 21